to try to get him on the straight narrows can look after government, we had hearings, for instance, mylan and pharmaceuticals, the epipen situation, you know, the arma boy where we did call into individual corporations but what we also did was call the fda and health and human services to say, how did this happen. what elijah cummings is doing demanding and sending out subpoenas and directives to go in letters and record amount to look under the books without any evidence of wrongdoing by the way, presupposing the outcome on fishing expeditions to go into the lives of individuals and if you have proximity to president trump, watch out, that's a prime target, the agreement which nobody has seen light of day between elijah cummings, nadler, adam schiff and i want to say there's a fifth one in about how they will do investigations and how they will do impeachment, this people layed this all out before the 116th congress even started but all premised on the idea that they were going to be essentially the campaign research arm for the democrats, i think that's what they are doing right here ri

. >> pfizer has hasn't covered dwr the deal wi mylan. >> pfizer tk a hit when you strip outri ge >> ager question for the ininstry and investors is political pressure on the pce medicine. there is intense congressional focus and the industry is a favorite punchg bag on the campaign trail. >> whether the pharmaceutical n andtry whose corrupt greed is killing people today. >> particularly for candidates like bernmy sanders and elizabeth warren. as warpen has rein ris 199police. health care stocks underperform according to a analysis. predominating theme in the street looks atab elh warren as anti-m and a. tti-competitive with resp to the deals we see in the market. >> the focus on drugg prices his home with company executives. merck told analyst says it exncctsasing pricer pressure in 2020. and pfizer ceo in ate telephone iew noted t impact on the reputation process. it'sd he said but lost in buckets saying it's a big problemeeding resved. for "nightly business report," meg tyrell. >> fellow dow component johnson o ashnson said it found best foss in the baby powder flagged by the fd pro

we had hearings mylan pharmaceutical and the epipen situation, farmer boy.id call into individual corporations but what we also did his call in the fda and health and human services to say, how did this happen? what elijah cummings is doing is now demanding and sending out subpoenas and directives to go, letters and records amounts to look under the books without any evidence of wrongdoing presupposing the outcome on fishing expeditions to go look into the lives of individuals. if you have proximity to donald trump, look out. that is a prime time target. this operating agreement, which nobody has seen the light of day between elijah cummings, jerry nadler, maxine Ãand i think there's a 51 about how they were going to do investigations and how they were going to do impeachment, these people lay this all out before the hundred 16th congress even started. but it's all promised on the idea that they were going to be essentially i believe the campaign research arm of the democrats. i think that's what they are doing right here, right now, there is no justificatio

issue -- >> from the stock -- >> but the jern nashg generics- >> yes, to that end, we used to own mylanand it was down in march. >> we finally started to see some activity come in on november 8 calls, scott. but it's not huge. it's like 8,000 contract which is is pretty good but it hasn't built from there >> i've got to go to kayla tausche in washington, d.c. with breaking news. >> the acting chief of staff mick mulvaney just announced that the u.s. will be hosting the g7 summit in june at the trump doral in miami it's going to produce questions and pushback from democrats from the extent that the president and his family may be profiting off of this event. white house officials have attempted to streamline thevane on global growth next year and of course, there are questions for what that means for the president's bottom line. >> kayla, there were questions when it was first brought up, and where it was debated and now that debate is not going to end anytime soon now that you have an official announcement >> no and it could perhaps be a legal battle, scott. at the time, when dora white

companies go on to completely different directions pfizer still trying to cover from investor reaction to mylanack in july moving to j&j the stock up more than 3% in the havre hours process. halted just before the the close. the news we got is that j&j conducted a third party laboratory testing thirtd party lab conducted testing of the bottle of baby powder that the fda said it found was contaminated with trace amounts of asbestos. and the two third party labs say they found no evidence of asbestos in the bottle withes also conducted a number of tests on the lot that j&j volunteerly recalled of baby poud err auto outlet of abundance of caution found none in that lot either. when we communicatewood the fda about finding they said there was no evidence of potential cross cams however, that is what j&j is saying could have happen here we are waiting to hear from back from the fd a what it thinks but j&j says no evidence of asbestos in the bottle in 40 years of testing. >> j&j two third party labs tested the same bottle of talc that the fda tested. >> that's right. >> so they're saying basically th

we had hearings, for instance, mylan pharmaceuticals and the end -- epipen situation, you know, the pharma boy where we did call in individual corporations. but what we also did is called in the fda and health and human services to say how does this happen? what elijiah cummings is doing is now demanding and sending out subpoenas and directives to go and letters in record amount to look under the books, without any evidence of wrongdoing, by the way. presupposing the outcomes on fishing expeditions to go look into the lives of individuals. and if you have proximity to donald trump, look out. because that is a prime time target. just offering an agreement, which nobody has seen the light of day between lie ya cummings, jerry nadler, adam schiff, maxine waters, and i want to say there's a fifth one in there about how they were going to do investigations and how they were going to do impeachment. these people laid this all out before the 116th congress even started. i think that's what they're doing right here, right now. there is no justification or evidence to you have a lot of -- to justif

mylan pharmaceuticals says the chances of infection are slim but cannot be ruled out.rmation is available on the fda's website. >>> and a tennessee man is suing the popeye's chicken chain for not having its very popular chicken sandwich. >> he claims popeye's conducted false advertising, deceptive business practices, and wasted his time. he also blames popeyes for damage to his car while in pursuit of the sandwich. >> but wait, there's more. the chattanooga man is seeking $5,000 when the case goes to trial in january. i could buy a lot of chicken sandwiches. but he may get a sandwich much sooner. popeyes says it will be back on sale everywhere this sunday, which is the real headline here. >> yeah, it is. the question, though, the sandwich returns, will the hype come with it? >> oh yeah. hands down. i do believe it will. >> yeah? >> and i think they'll have the supply ready, i hope they will, i hope they've learned. >> they've had two months to get things in order. >> so -- we have a little detail here of that man who's suing. he had $1,500 rims on his mercedes, he says

about the impeachment inquiry will take pressure off the space >> pfizer never recovered from the mylaneth warren's potential for becoming the democratic nominee has increased one would expect pharma would not be getting stronger either given her proposals. >> that's a great point. jeffries has tracked how elizabeth warren has done versus the performance of the xlv they perform inversely as elizabeth warren seems to do better against joe biden, drug stocks and health care stocks do worse because the industry is afraid of what she might do if she's elected. >> thank you is there anything in health care you do find attractive right now wean all this political it's hard i own a little bit of united health care. i would love to bit. i want to buy quality on sale. with this overhang you have time in terms of pharma and biotech it's very difficult. they should have been buying companies for so long. they have the cash flow. they just haven't. they don't have the growth now they are just yield plays if you well nothing wrong with that. you have to know what you own. i don't want to own somethi

that is what is going to remain after its spinoff and structured transaction with mylan.erck, we have again, up nearly 3% in the premarket. this is on some big, broad-based strengths. especially if you look at keith ata, the market-leading -- the market-leading cancer drug, it recently got approved in china, as well as the hpv vaccine. you are also seeing with that company is that not much guidance has been offered as to the ceos departure, who will but on financial guidance, we have the full-year adjusted eps upgraded to above the highest analyst estimate in this case. really changing up the picture, let's look at cummins inc., and engine maker. yesterday, we highlighted this stock and how we can be worried about recession when stocks like cummins are at 52 week highs. you might not be able to write this off as a one-off. while the eps view was kind of in-line, the top line was light. what stands out here is it is really one of those nhl all-star game from the past, north america versus the world. international sales were down 8% year on year. this caused the company to

it is not mylan., a national treasure, unbelievable >> a lot more stocks we're going to keep an eye on as we get you ready for the opening bell here. stick around a lot more "squawk on the street" coming right back. introducing even more value from fidelity. fidelity now has zero commissions for online u.s. equity trades and etfs. and fidelity also offers zero account fees for brokerage accounts, plus zero minimums to open an account. and only fidelity offers four zero expense ratio index funds directly to investors. with all of those zeros, there are zero reasons to invest anywhere else. fidelity. ♪ so maybe i'll win ♪ saved by zero ♪ so maybe i'll win ♪ ♪ i've been a caregiver for 20 years. no two patients are the same. predicting the next step for them can be challenging. today we're using the ibm cloud to run new analytics tools that help us better predict and plan a patient's recovery. ♪ ♪ ultimately, it's helping thousands of patients return home. and who doesn't love going home. was in an accid

drug ibrance and prevnar 13 merck in favor and pfizer still not yet covered from its july deal with mylan. wilf, back to you. >> hda also performing well today, helping that health care sector higher. >>> after the break, senator mark warner sending a letter to mark zuckerberg, asking him to rethink facebook's controversial political ad policy. we'll speak with the senator exclusively about that letter, next >>> plus, it's another massive afternoon for earnings with reports ahead from yay, mondelez, amgen, amd and many more we're going to bring you all of those numbers as soon as they hit. and as we head to break, here's a check on our data tracker. poe pending home sales raising and consumer confidence missed the mark driverless cars, or trips to mars. no commission. delivery drones, or the latest phones. no commission. no matter what you trade, at fidelity you'll pay no commission for online u.s. equity trades. at fidelity you'll pay no commission ♪ ♪ ♪ ♪ ♪ ♪ ♪ ♪ dana-farber cancer institute discovered the pd-l1 pathway. pd-l1. they changed how the world fights cancer. blocking the pd-l

this is from our friend, mylan burke, who sends this tweet. host: thank you for that.his is the editorial that was released two days ago and published this morning in "the new york times," mitch mcconnell calling the president's decision in syria a grave mistake. he writes the following -- -- mistak host: again, that from mitch mcconnell, taking aim at the trump administration and the president, though he does not mention the president by name. back to your phone calls, on the issue of political endorsements, do they influence your vote? john, thanks for waiting. good morning. one endorsement i'm really looking forward to is al gore's endorsement. if al gore endorses warren or biden,, perhaps even although i would be a bit surprised. i think that could really have an impact. just because the climate debate is so potent in the democratic primary right now that if there is one endorsement i'm really waiting for, it's that one. john, thank you for the call. ralph, good morning. guest: endorsements -- caller: endorsements have an influence on me when they come from people

mylan pharmaceuticals has been recalling it. tell me more.y are recalling the generic form of it. basically they are saying there's one lot of this drug that had a foreign substance in it present so they were calling all of it. they haven't had any reports of anything happening to anybody or any adverse effects but they are just trying to err on the side of safety. the announcement was on the fda's website over the weekend, and it seems to be something that they are, you know, currently in progress working on. stuart: it's not a widespread recall, just one -- jackie: one batch. stuart: all right. thanks, jackie. check the dow 30 because we just turned positive. we are now up, what, three points, two points. call it a dead flat market. i think i can get away with that. ashley: i think you can. stuart: general motors back in business after the strike which lasted more than a month. our next guest thinks the company has the right strategy going forward, relying on pickup trucks and suvs to power sales and make big money. we will let him make his

some comments on twitter from mylan who tweets trump's claim that killing abu bakr al-baghdadi is biggerhan killing osama bin laden, how unpatriotic of him. unlike president trump, i haven't forgot. he ruins even his best moments. let's hear from cindy in connecticut, republican line. caller: i am not surprised that trump is going to get criticized for this because he can't do anything right, it seems like. surprised theyll weren't told and they are mad because they weren't told because it was done in secret, so were the impeachment inquiry hearings, so take that. republicans had enough grief -- grace to complement obama because it was a good accomplishment weather you agreed with his politics -- whether you agreed with his politics or not. we should agree with this president. host: edward in maryland, democrats line. c-span.good morning, and i phd in sciences work for nasa at the spaceflight center. i am ashamed of this president and this action that took place in the capture of baghdadi, donald trump had absolutely nothing to do with that operation. our people happen to be in the right